Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Boston Scientific Corp (BSX)

33.565   0.015 (0.04%) 11-27 11:52
Open: 33.9 Pre. Close: 33.55
High: 33.9 Low: 33.445
Volume: 3,138,388 Market Cap: 48,062M
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 34.086 - 34.275 34.275 - 34.428
Low: 32.909 - 33.18 33.18 - 33.4
Close: 33.154 - 33.553 33.553 - 33.878

Technical analysis

as of: 2020-11-27 11:11:19 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 43.23     One year: 46.14
Support: Support1: 32.99    Support2: 27.45
Resistance: Resistance1: 37.01    Resistance2: 39.50
Pivot: 35.58
Moving Average: MA(5): 33.58     MA(20): 35.41
MA(100): 38.04     MA(250): 38.24
MACD: MACD(12,26): -1.01     Signal(9): -0.80
Stochastic oscillator: %K(14,3): 9.75     %D(3): 8.21
RSI: RSI(14): 36.47
52-week: High: 46.62  Low: 24.10  Change(%): -21.5
Average Vol(K): 3-Month: 1125153  10-Days: 1637451

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BSX has closed above bottom band by 23.1%. Bollinger Bands are 56.7% wider than normal. The large width of the bands suggest high volatility as compared to BSX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Wed, 25 Nov 2020
Boston Scientific Corporation (BSX) upgraded Issued by Wall Street Gurus - The News Heater

Mon, 23 Nov 2020
For Boston Scientific Corporation [BSX], Analyst sees a rise to $47. What next? - The DBT News

Fri, 20 Nov 2020
Boston Scientific Corporation (BSX) Just Got Our Attention | News Heater - The News Heater

Wed, 18 Nov 2020
Morgan Stanley Stick to Their Buy Rating for Boston Scientific Corp. -

Wed, 18 Nov 2020
Boston Scientific to lay off 106 after pulling heart device - Boston Business Journal

Tue, 17 Nov 2020
Boston Scientific to voluntarily recall LOTUS Edge aortic valve system due to snag with delivery system - MarketWatch

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 1,430
Shares Float (M) 1,430
% Held by Insiders 0.22
% Held by Institutions 93.26
Shares Short (K) 12,170
Shares Short P. Month (K) 12,920

Stock Financials

EPS 2.610
EPS Est This Year 1.250
EPS Est Next Year 1.410
Book Value (p.s.) 10.870
Profit Margin 36.64
Operating Margin 9.85
Return on Assets (ttm) 2.2
Return on Equity (ttm) 29.3
Qtrly Rev. Growth -1.8
Gross Profit (p.s.) 5.336
Sales Per Share 7.070
EBITDA (p.s.) 1.483
Qtrly Earnings Growth
Operating Cash Flow (M) 1,530
Levered Free Cash Flow (M) 2,170

Stock Valuations

PE Ratio 12.85
PEG Ratio 2.68
Price to Book value 3.09
Price to Sales 4.74
Price to Cash Flow 31.34

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.